US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Definium Therapeutics

43.27

-1.6400-3.65%

Post-market: 43.00-0.2669-0.62%19:56 EDT

Volume:1.73M

Turnover:74.54M

Market Cap:5.81B

PE:-12.43

High:44.46

Open:44.46

Low:41.25

Close:44.91

52wk High:49.70

52wk Low:8.70

Shares:134.37M

Float Shares:131.11M

Volume Ratio:0.95

T/O Rate:1.32%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.4823

EPS(LYR):-2.0600

ROE:-64.09%

ROA:-20.64%

PB:6.33

PE(LYR):-21.00

Loading ...

Overview Company News Filings

Definium Therapeutics (DFTX) Stock Gains After Hours: Here's What's Driving The Move

Benzinga_recent_news

Stock Track | Definium Therapeutics Soars 5.65% as Trump Executive Order Boosts Psychedelic Drug Sector

Psychedelic Stocks Surge After Trump Supports Using Drugs Like LSD for Mental Health

Definium Therapeutics issues inducement stock options for 70,860 shares to new hires

Definium Therapeutics: Policy Tailwinds and Late-Stage Clinical Momentum Support Attractive Risk‑Reward and Higher $38 Price Target

BUZZ-U.S. STOCKS ON THE MOVE-Adobe, Agios, QXO

Psychedelic Drug Stocks Surge with Compass Pathways up 37%; Atai Beckley up 28%. Trump Accelerates Psychedelic Research With $50 Million Ibogaine Commitment

Benzinga Earnings

Definium Therapeutics Adds 15.3%, Compass Pathways Rises 40%, GH Research Gains 16.4%

THOMSON REUTERS

Enveric Biosciences up 150%, U.S.‑Listed Shares of Cybin Rise 2.7%

THOMSON REUTERS

BUZZ-U.S. STOCKS ON THE MOVE-TopBuild, MDA Space, Biogen

Psychedelic Pharmaceutical Companies' Shares Rise Following Executive Order

Psychedelic Drug Developers Rise Premarket After Trump Orders FDA to Expedite Reviews

THOMSON REUTERS

Definium Therapeutics up 14.5%, Compass Pathways up 21.5%, GH Research up 18.9%, Enveric Biosciences up 6.6%, U.S.‑Listed Shares of Cybin up 15.5%

THOMSON REUTERS

BUZZ-Psychedelic drug developers rise after Trump signals regulatory support

Definium Therapeutics Inc - Supports White House Executive Order on Mental Health Innovation

THOMSON REUTERS

Definium Therapeutics Inc- Developing DT120 Odt for Generalized Anxiety Disorder, Major Depressive Disorder, and Other Serious Brain Health Disorders

THOMSON REUTERS

Definium Therapeutics backs White House order to accelerate psychedelic mental health treatments

Definium Therapeutics Anxiety Drug A Multi-Billion Opportunity: Analyst

Benzinga_recent_news

Stifel Initiates Definium Therapeutics at Buy With $30 Price Target

MT Newswires Live

Definium Therapeutics Inc : Stifel Initiates Coverage With Buy Rating; Price Target $30

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/DFTX/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"DFTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DFTX\",,,,,undefined,":{"symbol":"DFTX","market":"US","secType":"STK","nameCN":"Definium Therapeutics","latestPrice":43.27,"timestamp":1787601600000,"preClose":44.91,"halted":0,"volume":1727347,"hourTrading":{"tag":"盘后","latestPrice":43.0031,"preClose":43.27,"latestTime":"19:56 EDT","volume":28156,"amount":1218958.16756,"timestamp":1787615776201,"change":-0.2669,"changeRate":-0.006168,"amplitude":0.02434},"delay":0,"changeRate":-0.036517479403250806,"floatShares":131114280,"shares":134366950,"eps":-3.482311,"marketStatus":"Closed","change":-1.64,"latestTime":"08-24 16:00:00 EDT","open":44.46,"high":44.46,"low":41.25,"amount":74544367.99727,"amplitude":0.071476,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.482311,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787644800000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":44.91,"preHourTrading":{"tag":"盘前","latestPrice":44.53,"preClose":44.91,"latestTime":"09:29 EDT","volume":2695,"amount":120581.846,"timestamp":1787578170124,"change":-0.38,"changeRate":-0.008461,"amplitude":0.024271},"postHourTrading":{"tag":"盘后","latestPrice":43.0031,"preClose":43.27,"latestTime":"19:56 EDT","volume":28156,"amount":1218958.16756,"timestamp":1787615776201,"change":-0.2669,"changeRate":-0.006168,"amplitude":0.02434},"volumeRatio":0.954071,"optionData":{"bulkOrders":[{"symbol":"DFTX","call":true,"expireDate":1792123200000,"strike":"45.0","timestamp":1787579284670,"price":4.6,"volume":2000,"amount":920000,"type":"-"}]},"impliedVol":0.8534,"impliedVolPercentile":0.351},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DFTX\",,,,,undefined,":{"symbol":"DFTX","floatShares":131114280,"roa":"-20.64%","roe":"-64.09%","lyrEps":-2.059999,"volumeRatio":0.954071,"shares":134366950,"dividePrice":0,"high":44.46,"amplitude":0.071476,"preClose":44.91,"low":41.25,"week52Low":8.7,"pbRate":"6.33","week52High":49.7,"institutionHeld":0,"latestPrice":43.27,"eps":-3.482311,"divideRate":0,"volume":1727347,"delay":0,"ttmEps":-3.482311,"open":44.46,"prevYearClose":13.39,"prevWeekClose":44.91,"prevMonthClose":43.52,"prevQuarterClose":47.04,"fiveDayClose":45.26,"twentyDayClose":42.65,"sixtyDayClose":23.48},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DFTX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"DFTX","fiscalQuarterEnding":"2026/06","expectedEps":-0.55,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"post","actualEps":-1.44},{"market":"US","date":"2026-05-07","symbol":"DFTX","fiscalQuarterEnding":"2026/03","expectedEps":-0.47,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"post","actualEps":-0.71},{"market":"US","date":"2026-02-26","symbol":"DFTX","fiscalQuarterEnding":"2025/12","expectedEps":-0.45,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1772082000000,"reportTimeType":"post","actualEps":-0.45}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DFTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DFTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3889,"buy":0.6111,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6111,"analysts":18,"updateTime":1787198400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/DFTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"DFTX","date":"2026-08-21","current":-12.425656,"percent":0.221477,"low":-27.074722,"twenty":-17.526933,"median":-11.058518,"eighty":-9.861594,"high":-8.802064,"avg":-13.793358,"sd":5.619462,"marketCap":6100259530},"quantilePoints":[{"date":"2026-01-16","current":-9.013032,"twenty":-8.970838,"median":-8.907548,"eighty":-8.844258,"marketCap":1515072711},{"date":"2026-01-23","current":-9.944809,"twenty":-9.944809,"median":-9.423248,"eighty":-8.819645,"marketCap":1671702464},{"date":"2026-01-30","current":-10.103035,"twenty":-10.103035,"median":-9.868626,"eighty":-9.013032,"marketCap":1698299969},{"date":"2026-02-06","current":-9.522872,"twenty":-10.196799,"median":-9.918438,"eighty":-9.522872,"marketCap":1600775783},{"date":"2026-02-13","current":-9.511152,"twenty":-10.179218,"median":-9.944809,"eighty":-9.522872,"marketCap":1598805598},{"date":"2026-02-20","current":-10.120616,"twenty":-10.18039,"median":-9.944809,"eighty":-9.520528,"marketCap":1701255248},{"date":"2026-02-27","current":-9.267085,"twenty":-10.187422,"median":-9.96239,"eighty":-9.520528,"marketCap":1703225433},{"date":"2026-03-06","current":-9.519961,"twenty":-10.18039,"median":-9.903787,"eighty":-9.502065,"marketCap":1749702163},{"date":"2026-03-13","current":-9.753213,"twenty":-10.18039,"median":-9.918437,"eighty":-9.518199,"marketCap":1792572359},{"date":"2026-03-20","current":-10.122078,"twenty":-10.169841,"median":-9.903787,"eighty":-9.52229,"marketCap":1860367087},{"date":"2026-03-27","current":-10.273963,"twenty":-10.169841,"median":-9.918437,"eighty":-9.559599,"marketCap":1888282563},{"date":"2026-04-02","current":-11.174427,"twenty":-10.181562,"median":-9.918437,"eighty":-9.550417,"marketCap":2053781457},{"date":"2026-04-10","current":-11.619234,"twenty":-10.247114,"median":-9.944809,"eighty":-9.57529,"marketCap":2135533923},{"date":"2026-04-17","current":-12.18338,"twenty":-10.396104,"median":-9.980506,"eighty":-9.589394,"marketCap":2239219977},{"date":"2026-04-24","current":-12.617338,"twenty":-11.167918,"median":-10.038572,"eighty":-9.618687,"marketCap":2318978480},{"date":"2026-05-01","current":-11.86876,"twenty":-11.389236,"median":-10.10442,"eighty":-9.643639,"marketCap":2181395062},{"date":"2026-05-08","current":-13.767387,"twenty":-11.71579,"median":-10.122078,"eighty":-9.665202,"marketCap":2530349365},{"date":"2026-05-15","current":-9.802755,"twenty":-11.643102,"median":-10.113211,"eighty":-9.689477,"marketCap":2328575817},{"date":"2026-05-22","current":-10.399644,"twenty":-11.570414,"median":-10.105791,"eighty":-9.636028,"marketCap":2470362634},{"date":"2026-05-29","current":-10.780735,"twenty":-11.483622,"median":-10.120616,"eighty":-9.642537,"marketCap":2560888064},{"date":"2026-06-05","current":-11.290386,"twenty":-11.393576,"median":-10.145827,"eighty":-9.660184,"marketCap":2681952193},{"date":"2026-06-12","current":-11.069996,"twenty":-11.344489,"median":-10.179218,"eighty":-9.68473,"marketCap":2629600138},{"date":"2026-06-18","current":-11.216923,"twenty":-11.349156,"median":-10.196799,"eighty":-9.702279,"marketCap":2664501508},{"date":"2026-06-26","current":-20.565124,"twenty":-11.510745,"median":-10.247973,"eighty":-9.723056,"marketCap":4885101210},{"date":"2026-07-02","current":-24.252692,"twenty":-11.77112,"median":-10.299843,"eighty":-9.753213,"marketCap":5761057223},{"date":"2026-07-10","current":-27.074722,"twenty":-12.069466,"median":-10.333633,"eighty":-9.796609,"marketCap":6431410656},{"date":"2026-07-17","current":-24.643864,"twenty":-12.519698,"median":-10.492938,"eighty":-9.802755,"marketCap":5853977501},{"date":"2026-07-24","current":-23.990048,"twenty":-12.931958,"median":-10.537388,"eighty":-9.812883,"marketCap":5698667894},{"date":"2026-07-31","current":-24.861803,"twenty":-14.440728,"median":-10.67054,"eighty":-9.817222,"marketCap":5905747370},{"date":"2026-08-07","current":-17.312135,"twenty":-19.588062,"median":-10.789918,"eighty":-9.824231,"marketCap":6124773739},{"date":"2026-08-14","current":-16.673146,"twenty":-17.887875,"median":-10.831241,"eighty":-9.831914,"marketCap":5898709105},{"date":"2026-08-21","current":-17.242844,"twenty":-17.526933,"median":-11.058518,"eighty":-9.861594,"marketCap":6100259530}],"updateTime":1787625744025},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DFTX\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2629086910","title":"Definium Therapeutics (DFTX) Stock Gains After Hours: Here's What's Driving The Move","url":"https://stock-news.laohu8.com/highlight/detail?id=2629086910","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629086910?lang=en_us&edition=fundamental","pubTime":"2026-04-21 15:44","pubTimestamp":1776757440,"startTime":"0","endTime":"0","summary":"Definium Therapeutics stock rises after hours amid psychedelic sector rally following Trump's regulatory push.","market":"hk","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/04/21/Stock-Market-Analysis-Shows-Trading-Patt.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/04/21/Stock-Market-Analysis-Shows-Trading-Patt.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/markets/equities/26/04/51930842/definium-therapeutics-dftx-stock-gains-after-hours-heres-whats-driving-the-move","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/equities/26/04/51930842/definium-therapeutics-dftx-stock-gains-after-hours-heres-whats-driving-the-move","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168677170","title":"Stock Track | Definium Therapeutics Soars 5.65% as Trump Executive Order Boosts Psychedelic Drug Sector","url":"https://stock-news.laohu8.com/highlight/detail?id=1168677170","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168677170?lang=en_us&edition=fundamental","pubTime":"2026-04-21 10:07","pubTimestamp":1776737240,"startTime":"0","endTime":"0","summary":"Definium Therapeutics' stock surged 5.65% during Monday's trading session, mirroring gains across the psychedelic drug development sector following a significant regulatory announcement from the...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629779874","title":"Psychedelic Stocks Surge After Trump Supports Using Drugs Like LSD for Mental Health","url":"https://stock-news.laohu8.com/highlight/detail?id=2629779874","media":"Dow Jones","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629779874?lang=en_us&edition=fundamental","pubTime":"2026-04-21 09:54","pubTimestamp":1776736485,"startTime":"0","endTime":"0","summary":"An executive order aims to speed up how quickly psychedelic drugs for mental illness can move through the regulatory process","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Trump Supports Using Drugs Like LSD for Mental Health","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GHRS","BK4139","CMPS","BK4539","BK4007","DFTX","ATAI","HELP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629775545","title":"Definium Therapeutics issues inducement stock options for 70,860 shares to new hires","url":"https://stock-news.laohu8.com/highlight/detail?id=2629775545","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629775545?lang=en_us&edition=fundamental","pubTime":"2026-04-21 04:01","pubTimestamp":1776715282,"startTime":"0","endTime":"0","summary":"Definium Therapeutics issued inducement stock options covering 70,860 common shares to five newly hired non-executive employees.Grant dates were set for April 6, 2026 and April 20, 2026.Exercise price equals closing price of Definium common shares on each grant date.Vesting runs four years with 25% on first anniversary of grant date.Remaining 75% vests in substantially equal monthly installments over next three years, subject to continued employment.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Definium Therapeutics Inc. published the original content used to generate this news brief via Business Wire  on April 20, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nNDL2vgXzn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629775502","title":"Definium Therapeutics: Policy Tailwinds and Late-Stage Clinical Momentum Support Attractive Risk‑Reward and Higher $38 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2629775502","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629775502?lang=en_us&edition=fundamental","pubTime":"2026-04-21 03:55","pubTimestamp":1776714921,"startTime":"0","endTime":"0","summary":"Analyst Francois Brisebois of LifeSci Capital reiterated a Buy rating on Definium Therapeutics, boosting the price target to $38.00. Francois Brise...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/definium-therapeutics-policy-tailwinds-and-late-stage-clinical-momentum-support-attractive-risk‑reward-and-higher-38-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/definium-therapeutics-policy-tailwinds-and-late-stage-clinical-momentum-support-attractive-risk‑reward-and-higher-38-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SSI","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628226027","title":"BUZZ-U.S. STOCKS ON THE MOVE-Adobe, Agios, QXO","url":"https://stock-news.laohu8.com/highlight/detail?id=2628226027","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628226027?lang=en_us&edition=fundamental","pubTime":"2026-04-20 23:53","pubTimestamp":1776700380,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Adobe, Agios, QXOWorkspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: https://refi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nL6N41310S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLF","DVN","AGIO","HLXX","SRFM","GHRS","USAR","CDE","ADBE","ASTS","CMPS","FRMI","MVLL","FCX","JEF","XOMZ","PASG","ASTX","BLD","NEM","FCXG","AAL","CCL","OKTA","SIDU","GLSI","META","OXY","CVX","DFTX","SOC","ASTN","WHR","GTLB","RBC","ATAI","HL","BIIB","NKTR","JPMO","SF","XOM","LION","AMZN","MRVL","SCCO","OKTG","QXO","CLDX","USAW.SI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628511527","title":"Psychedelic Drug Stocks Surge with Compass Pathways up 37%; Atai Beckley up 28%. Trump Accelerates Psychedelic Research With $50 Million Ibogaine Commitment","url":"https://stock-news.laohu8.com/highlight/detail?id=2628511527","media":"Benzinga Earnings","labels":["movement","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628511527?lang=en_us&edition=fundamental","pubTime":"2026-04-20 22:32","pubTimestamp":1776695576,"startTime":"0","endTime":"0","summary":"On Saturday, President Donald Trump signed an executive order directing the U.S. Food and Drug Administration to move faster on reviews tied to psychedelic-based research and treatment, including...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/26/04/51902644/trump-accelerates-psychedelic-research-with-50-million-ibogaine-commitment","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":"Trump Accelerates Psychedelic Research With $50 Million Ibogaine Commitment","news_tag":"movement,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HELP","CMPS","DFTX","ATAI","GHRS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628726555","title":"Definium Therapeutics Adds 15.3%, Compass Pathways Rises 40%, GH Research Gains 16.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628726555","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628726555?lang=en_us&edition=fundamental","pubTime":"2026-04-20 21:32","pubTimestamp":1776691966,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nL4N4130YA:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ENVB","GHRS","BK4007","BK4539","CMPS","DFTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628726551","title":"Enveric Biosciences up 150%, U.S.‑Listed Shares of Cybin Rise 2.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628726551","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628726551?lang=en_us&edition=fundamental","pubTime":"2026-04-20 21:32","pubTimestamp":1776691966,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nL4N4130YA:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GHRS","DFTX","CMPS","BK4139","BK4539","ENVB","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628255037","title":"BUZZ-U.S. STOCKS ON THE MOVE-TopBuild, MDA Space, Biogen","url":"https://stock-news.laohu8.com/highlight/detail?id=2628255037","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628255037?lang=en_us&edition=fundamental","pubTime":"2026-04-20 21:05","pubTimestamp":1776690324,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-TopBuild, MDA Space, BiogenWorkspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: ht","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nL6N4130N2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JEF","META","RBC","OKTA","ASTS","XOMX","RIO.AU","SF","AMZN","BHP.AU","PASG","RIO.UK","GTLB","SCCO","CMPS","GLSI","SOC","CVX","DFTX","XOM","AALG","USAR","SRFM","DVN","JPMO","MRVL","NEM","CDE","QXO","NKTR","LION","ATAI","FCXG","GHRS","BLD","CCL","CLDX","FCX","HL","AAL","XOMO","AU","WHR","BIIB","NEMG","OXY","CLF","BMI","CCL.UK","FRMI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628445907","title":"Psychedelic Pharmaceutical Companies' Shares Rise Following Executive Order","url":"https://stock-news.laohu8.com/highlight/detail?id=2628445907","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628445907?lang=en_us&edition=fundamental","pubTime":"2026-04-20 18:39","pubTimestamp":1776681540,"startTime":"0","endTime":"0","summary":"Shares of several pharmaceutical companies were higher after President Trump signed an executive order aimed at accelerating research, development and access to psychedelic medicines for the treatment of mental illnesses.Definium Therapeutics' stock was up 15%, at $26.03, in premarket trading Monday. Shares of Compass Pathways rose 32%, to $8.78, while shares of Psyence Biomedical jumped 76%, to $13.37.The companies all released statements supporting the executive action.\"We applaud the administration's recognition that psychedelic medicines may represent meaningful new treatment options for patients,\" Definium Chief Executive Rob Barrow said, noting the company will advance a comprehensive clinical development program of its potential treatment for generalized anxiety disorder and major depressive disorder.Compass--which separately said Saturday it is conducting some of the largest, most robust classic psychedelic studies to date--noted it is actively working with the Food and Drug Ad","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMPS","BK4139","DFTX","PBM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628744309","title":"Psychedelic Drug Developers Rise Premarket After Trump Orders FDA to Expedite Reviews","url":"https://stock-news.laohu8.com/highlight/detail?id=2628744309","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628744309?lang=en_us&edition=fundamental","pubTime":"2026-04-20 18:37","pubTimestamp":1776681469,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nL4N4130NG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ENVB","ATAI","BK4139","BK4007","DFTX","GHRS","BK4539","CMPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628744304","title":"Definium Therapeutics up 14.5%, Compass Pathways up 21.5%, GH Research up 18.9%, Enveric Biosciences up 6.6%, U.S.‑Listed Shares of Cybin up 15.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628744304","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628744304?lang=en_us&edition=fundamental","pubTime":"2026-04-20 18:37","pubTimestamp":1776681469,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nL4N4130NG:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DFTX","ATAI","GHRS","BK4539","CMPS","ENVB","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628745460","title":"BUZZ-Psychedelic drug developers rise after Trump signals regulatory support","url":"https://stock-news.laohu8.com/highlight/detail?id=2628745460","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628745460?lang=en_us&edition=fundamental","pubTime":"2026-04-20 17:16","pubTimestamp":1776676569,"startTime":"0","endTime":"0","summary":"BUZZ-Psychedelic drug developers rise after Trump signals regulatory support** Shares of psychedelic drug developers rise premarket after U.S. President Donald Trump signed an executive order on Saturday, telling health regulators to speed up review of psychedelic drugs such as ibogaine and set aside $50 million for research** Shares of Atai ATAI.O jump 21%, Definium Therapeutics DFTX.O rise 18%, Compass Pathways CMPS.O climb 24%, GH Research GHRS.O gain 19%, Enveric ENVB.O add 7% before the bell** U.S.-listed shares of Cybin HELP.O up 15% ** Brokerage Jefferies says the order is an \"official stamp of validation to the class\", showing government support is \"real/actionable \"** Ibogaine is a naturally occurring psychoactive compound derived from an African shrub that is being studied as a potential treatment for addiction and mental health disorders** Psychedelic drugs with Breakthrough Therapy Designation may get Commissioner National Priority Review Vouchers, cutting FDA review from 6","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nL4N4130HR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMPS","DFTX","BK4539","GHRS","ENVB","BK4007","ATAI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628752745","title":"Definium Therapeutics Inc - Supports White House Executive Order on Mental Health Innovation","url":"https://stock-news.laohu8.com/highlight/detail?id=2628752745","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628752745?lang=en_us&edition=fundamental","pubTime":"2026-04-19 07:38","pubTimestamp":1776555532,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260418:nFWN41102Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628752069","title":"Definium Therapeutics Inc- Developing DT120 Odt for Generalized Anxiety Disorder, Major Depressive Disorder, and Other Serious Brain Health Disorders","url":"https://stock-news.laohu8.com/highlight/detail?id=2628752069","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628752069?lang=en_us&edition=fundamental","pubTime":"2026-04-19 07:38","pubTimestamp":1776555532,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260418:nFWN41102Y:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628752746","title":"Definium Therapeutics backs White House order to accelerate psychedelic mental health treatments","url":"https://stock-news.laohu8.com/highlight/detail?id=2628752746","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628752746?lang=en_us&edition=fundamental","pubTime":"2026-04-19 07:38","pubTimestamp":1776555499,"startTime":"0","endTime":"0","summary":"Definium Therapeutics backed a newly signed White House executive order aimed at accelerating research, development, and responsible access to treatments for serious mental illness, including psychedelic medicines.CEO Rob Barrow said psychedelic medicines could become meaningful new options for patients.Definium highlighted its late-stage clinical program for DT120  in generalized anxiety disorder, major depressive disorder.Company said streamlined regulatory pathways, cross-agency coordination could speed translation of innovation into care.Definium emphasized FDA evidence-based review as key route to delivering psychedelic therapies safely to patients.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Definium Therapeutics Inc. publishe","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260418:nNDL2QG6xg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628869017","title":"Definium Therapeutics Anxiety Drug A Multi-Billion Opportunity: Analyst","url":"https://stock-news.laohu8.com/highlight/detail?id=2628869017","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628869017?lang=en_us&edition=fundamental","pubTime":"2026-04-18 02:06","pubTimestamp":1776449160,"startTime":"0","endTime":"0","summary":"Stifel starts Definium coverage, citing strong DT120 potential in anxiety and key 2026 trial catalysts shaping outlook.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/04/17/Mental-Health-Care-Therapy-Concept--Psyc.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/04/17/Mental-Health-Care-Therapy-Concept--Psyc.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/analyst-stock-ratings/initiation/26/04/51894510/definium-therapeutics-anxiety-drug-a-multi-billion-opportunity-analyst","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/analyst-stock-ratings/initiation/26/04/51894510/definium-therapeutics-anxiety-drug-a-multi-billion-opportunity-analyst","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628036352","title":"Stifel Initiates Definium Therapeutics at Buy With $30 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2628036352","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628036352?lang=en_us&edition=fundamental","pubTime":"2026-04-17 19:28","pubTimestamp":1776425296,"startTime":"0","endTime":"0","summary":"Definium Therapeutics, Inc. (DFTX) has an average rating of buy and mean price target of $36.67, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research fr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SF","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628270715","title":"Definium Therapeutics Inc : Stifel Initiates Coverage With Buy Rating; Price Target $30","url":"https://stock-news.laohu8.com/highlight/detail?id=2628270715","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628270715?lang=en_us&edition=fundamental","pubTime":"2026-04-17 18:47","pubTimestamp":1776422838,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260417:nFWN410022:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":200,"code":"91000000","status":"200"}]}}